KNUSTSpace >
Theses / Dissertations >
College of Health Sciences >

Please use this identifier to cite or link to this item: http://hdl.handle.net/123456789/11881

Title: Good Quality of Life in Former Buruli Ulcer Patients with Small Lesions: Long-Term Follow-up of the BURULICO Trial
Authors: Klis, Sandor
Ranchor, Adelita
Phillips, Richard O.
Abass, Kabiru M.
Tuah, Wilson
et. al
Issue Date: 10-Jul-2014
Publisher: PLOS Neglected Tropical Diseases
Citation: PLoS Negl Trop Dis 8(7): e2964. doi:10.1371/journal.pntd.0002964
Abstract: Background: Buruli Ulcer is a tropical skin disease caused by Mycobacterium ulcerans, which, due to scarring and contractures can lead to stigma and functional limitations. However, recent advances in treatment, combined with increased public health efforts have the potential to significantly improve disease outcome. Objectives: To study the Quality of Life (QoL) of former Buruli Ulcer patients who, in the context of a randomized controlled trial, reported early with small lesions (cross-sectional diameter ,10 cm), and received a full course of antibiotic treatment. Methods: 127 Participants of the BURULICO drug trial in Ghana were revisited. All former patients aged 16 or older completed the Dermatology Life Quality Index (DLQI) and the abbreviated World Health Organization Quality of Life scale (WHOQOL-BREF). The WHOQOL-BREF was also administered to 82 matched healthy controls. Those younger than 16 completed the Childrens’ Dermatology Life Quality Index (CDLQI) only. Results: The median (Inter Quartile Range) score on the DLQI was 0 (0–4), indicating good QoL. 85% of former patients indicated no effect, or only a small effect of the disease on their current life. Former patients also indicated good QoL on the physical and psychological domains of the WHOQOL-BREF, and scored significantly higher than healthy controls on these domains. There was a weak correlation between the DLQI and scar size (r = 0.32; p,0.001). Conclusions: BU patients who report early with small lesions and receive 8 weeks of antimicrobial therapy have a good QoL at long-term follow-up. These findings contrast with the debilitating sequelae often reported in BU, and highlight the importance of early case detection.
Description: An article published PLOS Neglected Tropical Diseases
URI: http://hdl.handle.net/123456789/11881
Appears in Collections:College of Health Sciences

Files in This Item:

File Description SizeFormat
Good Quality of Life in Former Buruli Ulcer Patients with Small Lesions Long-Term Follow-up of the BURULICO Trial.PDF298.92 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.


Valid XHTML 1.0! DSpace Software Copyright © 2002-2010  Duraspace - Feedback